2018 American Transplant Congress
Cause of ESRD is Not Associated with Risk of Post-Transplant CMV Infection
University of Wisconsin Madison, Madison, WI.
Purpose: Cytomegalovirus (CMV) infection is commonly encountered following kidney transplantation and is associated with patient morbidity and mortality. While preventative pharmacotherapy is used to prevent…2018 American Transplant Congress
Immunoglobulin Replacement Therapy in Pediatric Renal Transplant Patients
University of Iowa Hospitals and Clinics, Iowa City, IA.
Immunoglobulin replacement therapy decreases infection frequency in patients with primary immunodeficiency; however, there is limited data regarding the use of intravenous immunoglobulin (IVIG) or subcutaneous…2018 American Transplant Congress
Transmission of Rabies through Solid Organ Transplant: A Big Issue in China
Urology, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Purpose To summarize and analyze the clinical characteristic, prophylaxis and treatment of rabies transmitted through solid organ transplant. Methods Four recipients and their donors diagnosed…2018 American Transplant Congress
Evaluation of Risk Factors for Progression of Low Level CMV Viremia in Solid Organ Transplant Recipients
Background: Low level CMV viremia is common, and may either progress to higher viral loads that require therapy, or may spontaneously resolve. The clinical predictors…2018 American Transplant Congress
Serum Beta-(1,3)-D-Glucan as a Case-Finding Tool during an Outbreak of Pneumocystitis jirovecii Pneumonia in Abdominal Transplant Patients
Division of Infectious Diseases, Montefiore Medical Center, Bronx, NY.
Background: Pneumocystis jirovecii pneumonia(PJP) in solid organ transplant (SOT) recipients carries significant morbidity and mortality. There is mounting evidence for ongoing risk of PJP in…2018 American Transplant Congress
Early versus Late Cytomegalovirus Prophylaxis after Kidney Transplant
Duke University Hospital, Durham, NC.
Background: Prophylaxis against cytomegalovirus (CMV) is recommended in high-risk patients (CMV D+/R-) and those who are CMVR+ and getting T-cell depletional therapy. It is unclear…2018 American Transplant Congress
Urinary Tract Infections after Renal Transplantation: Is Male Gender a Risk Factor for Resistant Microorganisms?
Nephrology, Marmara University, School of Medicine, Istanbul, Turkey.
Introduction: Renal transplantation is the most effective treatment method for patients with the end-stage renal disease. The most common infections among these patients are urinary…2018 American Transplant Congress
Natural History and Determinants of Infectious Complications after Kidney Transplantation: A Nationwide Prospective Population Based Cohort
Paris Transplant Group, Paris, France.
Background: Although Infectious complications are a major cause of morbidity and mortality in KTR, little is known about their natural history and determinants at a…2018 American Transplant Congress
Long-Term Outcome of Kidney Transplant Recipient with HTLV-1 Infection
BackgroundThe human T-lymphotropic virus (HTLV-I), which is endemic in southern Japan, is recognized as the cause of adult T cell leukemia-lymphoma (ATL) and HTLV-1-associated myelopathy…2018 American Transplant Congress
Efficacy and Safety of Acute Antibody Rejection Treatment in Pediatric Kidney Transplant Recipients
Purpose: Evaluate the efficacy and safety of acute antibody mediated rejection (AMR) treatment modalities in pediatric kidney transplant recipients (KTR).Methods: A single-center retrospective chart review…
- « Previous Page
- 1
- …
- 54
- 55
- 56
- 57
- 58
- …
- 84
- Next Page »